ArticleJournal for immunotherapy of cancer2022

Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers.

Laetitia Nebot-Bral et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.